Drug
Apriso Cap
Apriso Cap: highest development phase Phase 1, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| Apriso 0.375G ER CAP NCT03327558 | Phase 1 | Ulcerative Colitis |
Latest
No recent events.
Follow Apriso Cap on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.